Schedule 13D ownership disclosure
Anixa Biosciences Inc
Common Stock · CUSIP: 03528H109
Event date: 2026-01-05
- Filing-level shares
- 2,468,103.00
- Percent of class
- 7.0%
- Michael CatelaniReported CIK 0001689394
Shares: 2,468,103.00 · Class: 7.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-26-000691
- Form type
- SCHEDULE 13D/A
- Filer
- Anixa Biosciences Inc
- CIK
- CIK 715446
- Filed
- Jan 06, 2026
- Reporting period
- Jan 05, 2026
- Description
- Schedule 13D beneficial ownership